Antioxidant effect of Phyllanthus emblica extract prevents contrast-induced acute kidney injury

BMC Complementary and Alternative Medicine

Volumn 14, Issue , 2014, Pages

  Tasanarong, Adis ^a   Kongkham, Supranee ^a   Itharat, Arunporn ^a  

^a THAMMASAT UNIVERSITY   (Thailand)

Author keywords

Antioxidant; Contrast induced acute kidney injury; Gallic acid; Phyllanthus emblica

Indexed keywords

CATALASE; CREATININE; EMBLICA OFFICINALIS EXTRACT; IOPROMIDE; MALONALDEHYDE; SUPEROXIDE DISMUTASE; UREA; ANTIOXIDANT; CONTRAST MEDIUM; PLANT EXTRACT;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTRAST INDUCED ACUTE KIDNEY INJURY; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; EMBLICA OFFICINALIS; ENZYME ACTIVITY; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY TUBULE NECROSIS; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; RENAL PROTECTION; SPRAGUE DAWLEY RAT; UREA NITROGEN BLOOD LEVEL; ACUTE KIDNEY INJURY; ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; HUMAN; KIDNEY; METABOLISM; DISEASE SEVERITY;

ACUTE KIDNEY INJURY; ANIMALS; ANTIOXIDANTS; CONTRAST MEDIA; HUMANS; KIDNEY; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; PHYLLANTHUS EMBLICA; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE;

EID: 84901852493     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-14-138     Document Type: Article

References (53)

1. Berns AS. Nephrotoxicity of contrast media. Kidney Int 1989, 36(4):730-740. 10.1038/ki.1989.254, 2681935.
2. Rudnick MR, Goldfarb S, Tumlin J. Contrast-induced nephropathy: is the picture any clearer?. Clin J Am Soc Nephrol 2008, 3(1):261-262. 10.2215/CJN.04951107, 18077780.
3. Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM, Pichard AD, Satler LF, Leon MB. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000, 36(5):1542-1548. 10.1016/S0735-1097(00)00917-7, 11079656.
4. Brezis M, Rosen S. Hypoxia of the renal medulla-its implications for disease. N Engl J Med 1995, 332(10):647-655. 10.1056/NEJM199503093321006, 7845430.
5. Tumlin J, Stacul F, Adam A, Becker CR, Davidson C, Lameire N, McCullough PA. Pathophysiology of contrast-induced nephropathy. Am J Cardiol 2006, 98(6A):14K-20K.
6. Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, Marsch S, Roskamm H. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002, 162(3):329-336. 10.1001/archinte.162.3.329, 11822926.
7. ACT Investigators Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). Circulation 2011, 124(11):1250-1259. ACT Investigators.
8. Spargias K, Alexopoulos E, Kyrzopoulos S, Iokovis P, Greenwood DC, Manginas A, Voudris V, Pavlides G, Buller CE, Kremastinos D, Cokkinos DV. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 2004, 110(18):2837-2842. 10.1161/01.CIR.0000146396.19081.73, 15492300.
9. Li Y, Liu Y, Fu L, Mei C, Dai B. Efficacy of short-term high-dose statin in preventing contrast-induced nephropathy: a meta-analysis of seven randomized controlled trials. PLoS One 2012, 7(4):e34450. 10.1371/journal.pone.0034450, 3325242, 22511942.
10. Tarwadi K, Agte V. Antioxidant and micronutrient potential of common fruits available in the Indian subcontinent. Int J Food Sci Nutr 2007, 58(5):341-349. 10.1080/09637480701243905, 17558726.
11. Krishnaveni M, Mirunalini S. Therapeutic potential of Phyllanthus emblica (amla): the ayurvedic wonder. J Basic Clin Physiol Pharmacol 2010, 21(1):93-105.
12. Kumaran A, Karunakaran RJ. Nitric oxide radical scavenging active components from Phyllanthus emblica L. Plant Foods Hum Nutr 2006, 61(1):1-5. 10.1007/s11130-006-0001-0, 16688481.
13. Zhang YJ, Tanaka T, Iwamoto Y, Yang CR, Kouno I. Novel norsesquiterpenoids from the roots of Phyllanthus emblica. J Nat Prod 2000, 63(11):1507-1510. 10.1021/np000135i, 11087593.
14. Ngamkitidechakul C, Jaijoy K, Hansakul P, Soonthornchareonnon N, Sireeratawong S. Antitumour effects of Phyllanthus emblica L.: induction of cancer cell apoptosis and inhibition of in vivo tumour promotion and in vitro invasion of human cancer cells. Phytother Res 2010, 24(9):1405-1413. 10.1002/ptr.3127, 20812284.
15. Baliga MS, Dsouza JJ. Amla (Emblica officinalis Gaertn), a wonder berry in the treatment and prevention of cancer. Eur J Cancer Prev 2011, 20(3):225-239. 10.1097/CEJ.0b013e32834473f4, 21317655.
16. Singh I, Soyal D, Goyal PK. Emblica officinalis (Linn.) fruit extract provides protection against radiation-induced hematological and biochemical alterations in mice. J Environ Pathol Toxicol Oncol 2006, 25(4):643-654. 10.1615/JEnvironPatholToxicolOncol.v25.i4.40, 17341205.
17. Ihantola-Vormisto A, Summanen J, Kankaanranta H, Vuorela H, Asmawi ZM, Moilanen E. Anti-inflammatory activity of extracts from leaves of Phyllanthus emblica. Planta Med 1997, 63(6):518-524. 10.1055/s-2006-957754, 9434603.
18. Bandyopadhyay SK, Pakrashi SC, Pakrashi A. The role of antioxidant activity of Phyllanthus emblica fruits on prevention from indomethacin induced gastric ulcer. J Ethnopharmacol 2000, 70(2):171-176. 10.1016/S0378-8741(99)00146-4, 10771207.
19. Kusirisin W, Srichairatanakool S, Lerttrakarnnon P, Lailerd N, Suttajit M, Jaikang C, Chaiyasut C. Antioxidative activity, polyphenolic content and anti-glycation effect of some Thai medicinal plants traditionally used in diabetic patients. Med Chem 2009, 5(2):139-147. 10.2174/157340609787582918, 19275712.
20. Agmon Y, Peleg H, Greenfeld Z, Rosen S, Brezis M. Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest 1994, 94(3):1069-1075. 10.1172/JCI117421, 295165, 8083347.
21. Kongkham S, Sriwong S, Tasanarong A. Protective effect of alpha tocopherol on contrast-induced nephropathy in rats. Nefrologia 2013, 33(1):116-123.
22. Reichman J, Cohen S, Goldfarb M, Shina A, Rosen S, Brezis M, Karmeli F, Heyman SN. Renal effects of nabumetone, a COX-2 antagonist: impairment of function in isolated perfused rat kidneys contrasts with preserved renal function in vivo. Exp Nephrol 2001, 9(6):387-396. 10.1159/000052637, 11701998.
23. Yamasowa H, Shimizu S, Inoue T, Takaoka M, Matsumura Y. Endothelial nitric oxide contributes to the renal protective effects of ischemic preconditioning. J Pharmacol Exp Ther 2005, 312(1):153-159.
24. Toprak O, Cirit M, Tanrisev M, Yazici C, Canoz O, Sipahioglu M, Uzum A, Ersoy R, Sozmen EY. Preventive effect of nebivolol on contrast-induced nephropathy in rats. Nephrol Dial Transplant 2008, 23(3):853-859.
25. Tasanarong A, Vohakiat A, Hutayanon P, Piyayotai D. New strategy of alpha- and gamma-tocopherol to prevent contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures. Nephrol Dial Transplant 2013, 28(2):337-344. 10.1093/ndt/gfs525, 23314316.
26. Wong SH, Knight JA, Hopfer SM, Zaharia O, Leach CN, Sunderman FW. Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem 1987, 33(2 Pt 1):214-220.
27. Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 1999, 26(9-10):1231-1237.
28. Aebi H. Catalase in vitro. Methods Enzymol 1984, 105:121-126.
29. Pisani A, Sabbatini M, Riccio E, Rossano R, Andreucci M, Capasso C, De Luca V, Carginale V, Bizzarri M, Borrelli A, Schiattarella A, Santangelo M, Mancini A. Effect of a recombinant manganese superoxide dismutase on prevention of contrast-induced acute kidney injury. Clin Exp Nephrol 2013, 17(3). Jun 27.
30. Wang YX, Jia YF, Chen KM, Morcos SK. Radiographic contrast media induced nephropathy: experimental observations and the protective effect of calcium channel blockers. Br J Radiol 2001, 74(888):1103-1108.
31. Detrenis S, Meschi M, Musini S, Savazzi G. Lights and shadows on the pathogenesis of contrast-induced nephropathy: state of the art. Nephrol Dial Transplant 2005, 20(8):1542-1550. 10.1093/ndt/gfh868, 16033768.
32. Zager RA, Johnson AC, Hanson SY. Radiographic contrast media-induced tubular injury: evaluation of oxidant stress and plasma membrane integrity. Kidney Int 2003, 64(1):128-139. 10.1046/j.1523-1755.2003.00059.x, 12787403.
33. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003, 348(6):491-499. 10.1056/NEJMoa021833, 12571256.
34. Jo SH, Koo BK, Park JS, Kang HJ, Kim YJ, Kim HL, Chae IH, Choi DJ, Sohn DW, Oh BH, Park YB, Choi YS, Kim HS. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial. Am Heart J 2009, 157(3):576-583. 10.1016/j.ahj.2008.11.010, 19249432.
35. Albabtain MA, Almasood A, Alshurafah H, Alamri H, Tamim H. Efficacy of ascorbic acid, N-acetylcysteine, or combination of both on top of saline hydration versus saline hydration alone on prevention of contrast-Induced nephropathy: a prospective randomized study. J Interv Cardiol 2013, 26(1):90-96. 10.1111/j.1540-8183.2012.00767.x, 22994682.
36. Sun Z, Fu Q, Cao L, Jin W, Cheng L, Li Z. Intravenous N-acetylcysteine for prevention of contrast-induced nephropathy: a meta-analysis of randomized, controlled trials. PLoS One 2013, 8(1):e55124. 10.1371/journal.pone.0055124, 3559541, 23383076.
37. Sai Ram M, Neetu D, Yogesh B, Anju B, Dipti P, Pauline T, Sharma SK, Sarada SK, Ilavazhagan G, Kumar D, Selvamurthy W. Cyto-protective and immunomodulating properties of Amla (Emblica officinalis) on lymphocytes: an in-vitro study. J Ethnopharmacol 2002, 81(1):5-10. 10.1016/S0378-8741(01)00421-4, 12020921.
38. Rajak S, Banerjee SK, Sood S, Dinda AK, Gupta YK, Gupta SK, Maulik SK. Emblica officinalis causes myocardial adaptation and protects against oxidative stress in ischemic-reperfusion injury in rats. Phytother Res 2004, 18(1):54-60. 10.1002/ptr.1367, 14750202.
39. Chen TS, Liou SY, Chang YL. Supplementation of Emblica officinalis (Amla) extract reduces oxidative stress in uremic patients. Am J Chin Med 2009, 37(1):19-25. 10.1142/S0192415X09006680, 19222108.
40. Tasanarong A, Piyayotai D, Thitiarchakul S. Protection of radiocontrast induced nephropathy by vitamin E (alpha tocopherol): a randomized controlled pilot study. J Med Assoc Thai 2009, 92(10):1273-1281.
41. Scartezzini P, Speroni E. Review on some plants of Indian traditional medicine with antioxidant activity. J Ethnopharmacol 2000, 71(1-2):23-43.
42. Habib Ur R, Yasin KA, Choudhary MA, Khaliq N, Atta Ur R, Choudhary MI, Malik S. Studies on the chemical constituents of Phyllanthus emblica. Nat Prod Res 2007, 21(9):775-781. 10.1080/14786410601124664, 17763100.
43. Reddy MB, Love M. The impact of food processing on the nutritional quality of vitamins and minerals. Adv Exp Med Biol 1999, 459:99-106. 10.1007/978-1-4615-4853-9_7, 10335371.
44. Van Acker SA, Van den Berg DJ, Tromp MN, Griffioen DH, Van Bennekom WP, Van der Vijgh WJ, Bast A. Structural aspects of antioxidant activity of flavonoids. Free Radic Biol Med 1996, 20(3):331-342. 10.1016/0891-5849(95)02047-0, 8720903.
45. Lu Z, Nie G, Belton PS, Tang H, Zhao B. Structure-activity relationship analysis of antioxidant ability and neuroprotective effect of gallic acid derivatives. Neurochem Int 2006, 48(4):263-274. 10.1016/j.neuint.2005.10.010, 16343693.
46. Stupans I, Kirlich A, Tuck KL, Hayball PJ. Comparison of radical scavenging effect, inhibition of microsomal oxygen free radical generation, and serum lipoprotein oxidation of several natural antioxidants. J Agric Food Chem 2002, 50(8):2464-2469. 10.1021/jf0112320, 11929315.
47. Nabavi SF, Habtemariam S, Jafari M, Sureda A, Nabavi SM. Protective role of gallic acid on sodium fluoride induced oxidative stress in rat brain. Bull Environ Contam Toxicol 2012, 89(1):73-77. 10.1007/s00128-012-0645-4, 22531840.
48. Stanely Mainzen Prince P, Priscilla H, Devika PT. Gallic acid prevents lysosomal damage in isoproterenol induced cardiotoxicity in Wistar rats. Eur J Pharmacol 2009, 615(1-3):139-143.
49. Vijaya Padma V, Sowmya P, Arun Felix T, Baskaran R, Poornima P. Protective effect of gallic acid against lindane induced toxicity in experimental rats. Food Chem Toxicol 2011, 49(4):991-998. 10.1016/j.fct.2011.01.005, 21219962.
50. Prasad L, Khan TH, Jahangir T, Sultana S. Effect of gallic acid on renal biochemical alterations in male Wistar rats induced by ferric nitriloacetic acid. Hum Exp Toxicol 2006, 25(9):523-529. 10.1191/0960327106het652oa, 17017005.
51. Peng CC, Hsieh CL, Wang HE, Chung JY, Chen KC, Peng RY. Ferulic acid is nephrodamaging while gallic acid is renal protective in long term treatment of chronic kidney disease. Clin Nutr 2012, 31(3):405-414. 10.1016/j.clnu.2011.11.003, 22154988.
52. Ferruzzi MG, Lobo JK, Janle EM, Cooper B, Simon JE, Wu QL, Welch C, Ho L, Weaver C, Pasinetti GM. Bioavailability of gallic acid and catechins from grape seed polyphenol extract is improved by repeated dosing in rats: implications for treatment in Alzheimer's disease. J Alzheimers Dis 2009, 18(1):113-124. 2801429, 19625746.
53. Da Silva SL, Chaar Jda S, Yano T. Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae). Eur J Pharmacol 2009, 608(1-3):76-83.